Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Triglycerides, particularly in the form of medium-chain triglycerides (MCTs), have scientific validation for their use in supporting fat metabolism, especially in individuals with impaired fat metabolism. MCTs are more rapidly absorbed and metabolized compared to long-chain triglycerides (LCTs) because they do not require bile salts for digestion and are transported directly to the liver via the portal vein. This unique metabolic pathway allows MCTs to be a preferred energy source in various clinical contexts, such as in patients with malabsorption syndromes, certain liver disorders, pancreatic insufficiency, or other conditions that compromise normal fat digestion and absorption (J Clin Gastroenterol 2013;47(8):675-685). Clinical guidelines and studies support the use of MCTs to provide calories and essential fatty acids in these populations, as they can compensate for the inability to efficiently metabolize regular dietary fats.

However, the use of generic "mixed triglycerides" (a combination of MCTs and LCTs) is less specifically validated, as it is usually the MCT fraction that confers the metabolic benefit. There is moderate-to-strong evidence for the use of MCTs in clinical nutrition, and they are a standard component in specialized medical foods for fat malabsorption (Curr Opin Clin Nutr Metab Care 2008;11(6):679-683). While more research is warranted for broader populations, the use of MCTs for poor fat metabolism is well-established in medical practice.

More about Triglycerides (mixed)
More about Fat Metabolism (poor)

Other ingredients used for Fat Metabolism (poor)

Other health conditions supported by Triglycerides (mixed)

Products containing Triglycerides (mixed)